423 Stock Overview
Dong-E-E-Jiao Co.,Ltd. produces and sells Chinese medicine, health care products, and biological drugs in China.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Dong-E-E-Jiao Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥67.75 |
52 Week High | CN¥70.80 |
52 Week Low | CN¥44.52 |
Beta | 0.67 |
1 Month Change | 13.09% |
3 Month Change | 29.91% |
1 Year Change | 31.81% |
3 Year Change | 90.31% |
5 Year Change | 54.72% |
Change since IPO | 17.42% |
Recent News & Updates
Recent updates
Shareholder Returns
423 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -2.1% | 0.8% | -0.4% |
1Y | 31.8% | -13.4% | -14.4% |
Return vs Industry: 000423 exceeded the CN Pharmaceuticals industry which returned -13.4% over the past year.
Return vs Market: 000423 exceeded the CN Market which returned -14.4% over the past year.
Price Volatility
423 volatility | |
---|---|
423 Average Weekly Movement | 4.7% |
Pharmaceuticals Industry Average Movement | 7.7% |
Market Average Movement | 8.8% |
10% most volatile stocks in CN Market | 12.7% |
10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 000423's share price has been volatile over the past 3 months.
Volatility Over Time: 000423's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1952 | 3,678 | Jie Cheng | www.dongeejiao.com |
Dong-E-E-Jiao Co.,Ltd. produces and sells Chinese medicine, health care products, and biological drugs in China. It offers compound donkey-hide gelatin paste, Enwei compound Ejiao pulp, donkey-hide gelatin jujube, Ejiao Buxue granules, and collagen powders.
Dong-E-E-Jiao Co.,Ltd. Fundamentals Summary
423 fundamental statistics | |
---|---|
Market cap | CN¥43.63b |
Earnings (TTM) | CN¥1.15b |
Revenue (TTM) | CN¥4.72b |
37.9x
P/E Ratio9.3x
P/S RatioIs 423 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
423 income statement (TTM) | |
---|---|
Revenue | CN¥4.72b |
Cost of Revenue | CN¥1.40b |
Gross Profit | CN¥3.32b |
Other Expenses | CN¥2.17b |
Earnings | CN¥1.15b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
Earnings per share (EPS) | 1.79 |
Gross Margin | 70.37% |
Net Profit Margin | 24.41% |
Debt/Equity Ratio | 0% |
How did 423 perform over the long term?
See historical performance and comparison